Rare variants in GPR3 in POI patients: a case series with review of literature

Shuting Ren1, Feng Zhang1,2, Lingyue Shang1

  • 1Obstetrics and Gynecology Hospital, NHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), State Key Laboratory of Genetic, Engineering at School of Life Sciences, Fudan University, Shanghai, 200011, China.

PubMed
Abstract

Insights

Rare variants in the G protein-coupled receptor 3 (GPR3) gene were identified in women with premature ovarian insufficiency (POI). This finding highlights GPR3 as a potential genetic cause for POI and a target for screening.

Area of Science:

  • Genetics
  • Reproductive Biology
  • Endocrinology

Background:

  • Premature ovarian insufficiency (POI) is a complex condition with up to 25% of cases having a genetic basis.
  • G protein-coupled receptor 3 (GPR3) is implicated in oocyte arrest, and its deficiency in mice leads to POI-like symptoms.

Conclusions:

  • This is the first report linking rare GPR3 variants to premature ovarian insufficiency (POI) in women.
  • GPR3 is proposed as a candidate gene for POI, warranting screening in affected individuals.
  • The findings emphasize the importance of including GPR3 in the etiological studies and genetic counseling for POI patients.